403 Forbidden


nginx
403 Forbidden

403 Forbidden


nginx
Follow us:
403 Forbidden

403 Forbidden


nginx

Northwest Voices

Seattle Times letters to the editor

October 27, 2014 at 7:05 AM

Ebola: Pharmaceutical companies need to find their soul

The Ebola epidemic has dominated the news since it broke out [“Nurse criticizes Ebola quarantine, raising concern,” Nation & World, Oct. 26]. Many questions are being asked, but one question not being asked is: “Where are the pharmaceutical companies?

Ebola is an unprofitable disease from the standpoint of the bottom line. Why develop a vaccine for a disease that mainly exists in poor countries? Also, where is the profit in developing any vaccine, since it is used only once or twice per person, as opposed to drugs for chronic diseases such as diabetes, heart disease or erectile dysfunction?

Haven’t we seen this before with HIV? It took years of advocacy and protest to drag the drug companies kicking and screaming into developing effective treatments for AIDS and HIV. Then it was like a miracle happened, and that particular plague was arrested, at least in developed countries.

No one is asking the drug companies to be totally altruistic and not make a good profit. They could do this by offsetting the research costs for inexpensive treatments by the highly profitable ones. Jesus said, “What does it profit a man if he gains the whole world and loses his soul?” Since corporations are now considered “people”, have the pharmaceutical companies lost their collective souls?

Sandy Renner, Seattle

Comments | More in Ebola | Topics: disease, Ebola, Pharmaceutical companies

COMMENTS

No personal attacks or insults, no hate speech, no profanity. Please keep the conversation civil and help us moderate this thread by reporting any abuse. See our Commenting FAQ.



The opinions expressed in reader comments are those of the author only, and do not reflect the opinions of The Seattle Times.


403 Forbidden

403 Forbidden


nginx
403 Forbidden

403 Forbidden


nginx